A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AJU-S56 in Patients With Dry Eye Disease
Latest Information Update: 10 Apr 2024
At a glance
- Drugs AJU S56 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors AJU Pharm
Most Recent Events
- 02 Apr 2024 New trial record